ANO1 has been shown to be amplified and highly expressed in several human carcinomas, including gastrointestinal stromal tumors, head and neck squamous carcinoma (HNSCC),3 esophageal squamous carcinoma (ESCC), and breast cancer (2, –, 7). Here, ANO1 is linked to breast carcinoma.